Details for gene: ATXN2


Interacting selectively and non-covalently with an RNA molecule or a portion thereof.


Symbol
ATXN2
Name
ataxin 2
Entrez ID
6311
Ensembl ID
ENSG00000204842    (more details)
KEGG ID
hsa:6311    (more details)
OMIM ID
601517
Uniprot ID
Q99700  
GO ID
hsa:6311    (more details)
Chromosome
12
Strand
-1
Start
111443485
End
111599676
miRNA Interactions
hsa-miR-4524a-5p (RPM: 0.0932) / hsa-miR-544b (RPM: 0.0056) / hsa-miR-182-5p (RPM: 77446.6216) / hsa-let-7b-5p (RPM: 3396.2052) / hsa-let-7f-5p (RPM: 17066.6836) / hsa-let-7c-5p (RPM: 4028.6728) / hsa-miR-1301-3p (RPM: 47.2112) / hsa-miR-589-5p (RPM: 54.2348) / hsa-let-7i-5p (RPM: 2025.2084) / hsa-miR-98-5p (RPM: 1660.0964) / hsa-let-7e-5p (RPM: 3790.2074) / hsa-let-7g-5p (RPM: 3559.4376) / hsa-miR-488-3p (RPM: 11.3394) / hsa-let-7a-5p (RPM: 32160.4734) / hsa-miR-4500 (RPM: 0.0022) / hsa-miR-301a-3p (RPM: 142.8494) / hsa-miR-1226-3p (RPM: 2.778) / hsa-miR-4664-5p (RPM: 0.02) / hsa-miR-150-3p (RPM: 0.6128) / hsa-miR-500a-5p (RPM: 1.3064) / hsa-miR-203a-3p (RPM: 1346.5646) / hsa-let-7d-5p (RPM: 1078.3154) / hsa-miR-4458 (RPM: 0.0998) / hsa-miR-342-5p (RPM: 28.1628) / hsa-miR-141-5p (RPM: 20.664) / hsa-miR-1915-5p (RPM: 0.0172) / hsa-miR-31-5p (RPM: 310.1326) / hsa-miR-491-5p (RPM: 1.4644) / hsa-miR-3177-5p (RPM: 0.1208) / hsa-miR-4726-5p (RPM: 0.184) / hsa-miR-4640-5p (RPM: 0.0282) / hsa-miR-574-5p (RPM: 176.4618) / hsa-miR-4519 (RPM: 0.1126) / hsa-miR-299-3p (RPM: 3.441) / hsa-miR-3151-5p (RPM: 0.0224) / hsa-miR-3940-5p (RPM: 0.0604) / hsa-miR-181a-2-3p (RPM: 1451.5764) / hsa-miR-2682-3p (RPM: 0.3262) / hsa-miR-27a-5p (RPM: 7.3838) / hsa-miR-124-5p (RPM: 23.3116) / hsa-miR-2114-3p (RPM: 8.8196) / hsa-miR-3200-3p (RPM: 32.0156) / hsa-miR-4507 (RPM: 0.038) / hsa-miR-4746-5p (RPM: 0.6238) / hsa-miR-374b-3p (RPM: 5.4276) / hsa-miR-4651 (RPM: 0.0744) / hsa-miR-4436b-5p (RPM: 0.0032) / hsa-miR-522-5p (RPM: 0.0018) / hsa-miR-10b-5p (RPM: 14052.6542) / hsa-miR-6793-5p (RPM: 0.0736) / hsa-miR-6747-5p (RPM: 0.0046) / hsa-miR-6737-5p (RPM: 0.0038) / hsa-miR-6812-5p (RPM: 0.013) / hsa-miR-6766-5p (RPM: 0.0116) / hsa-miR-3691-3p (RPM: 0.0432) / hsa-miR-6769b-5p (RPM: 0.003) / hsa-miR-6823-3p (RPM: 0.0024) / hsa-miR-6781-3p (RPM: 0.0624) / hsa-miR-6509-3p (RPM: 0.0334) / hsa-miR-6769a-5p (RPM: 0.0464) / hsa-miR-6742-5p (RPM: 0.0052) / hsa-miR-6796-5p (RPM: 0.1174) / hsa-miR-6508-3p (RPM: 0.244) /
Involved Diseases
primary open-angle glaucoma / glaucoma /
Involved Pathways
Amyotrophic lateral sclerosis (ALS) / Pathways of neurodegeneration - multiple diseases / Spinocerebellar ataxia /
Sequence
ATGTCGCTGAAGCCCCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAACAGCAGCAGCAGCAGCAGCAGCAGCAGCCGCCGCCCGCGGCTGCCAATGTCCGCAAGCCCGGCGGCAGCGGCCTTCTAGCGTCGCCCGCCGCCGCGCCTTCGCCGTCCTCGTCCTCGGTCTCCTCGTCCTCGGCCACGGCTCCCTCCTCGGTGGTCGCGGCGACCTCCGGCGGCGGGAGGCCCGGCCTGGGCAGAGGTCGAAACAGTAACAAAGGACTGCCTCAGTCTACGATTTCTTTTGATGGAATCTATGCAAATATGAGGATGGTTCATATACTTACATCAGTTGTTGGCTCCAAATGTGAAGTACAAGTGAAAAATGGAGGTATATATGAAGGAGTTTTTAAAACTTACAGTCCGAAGTGTGATTTGGTACTTGATGCCGCACATGAGAAAAGTACAGAATCCAGTTCGGGGCCGAAACGTGAAGAAATAATGGAGAGTATTTTGTTCAAATGTTCAGACTTTGTTGTGGTACAGTTTAAAGATATGGACTCCAGTTATGCAAAAAGAGATGCTTTTACTGACTCTGCTATCAGTGCTAAAGTGAATGGCGAACACAAAGAGAAGGACCTGGAGCCCTGGGATGCAGGTGAACTCACAGCCAATGAGGAACTTGAGGCTTTGGAAAATGACGTATCTAATGGATGGGATCCCAATGATATGTTTCGATATAATGAAGAAAATTATGGTGTAGTGTCTACGTATGATAGCAGTTTATCTTCGTATACAGTGCCCTTAGAAAGAGATAACTCAGAAGAATTTTTAAAACGGGAAGCAAGGGCAAACCAGTTAGCAGAAGAAATTGAGTCAAGTGCCCAGTACAAAGCTCGAGTGGCCCTGGAAAATGATGATAGGAGTGAGGAAGAAAAATACACAGCAGTTCAGAGAAATTCCAGTGAACGTGAGGGGCACAGCATAAACACTAGGGAAAATAAATATATTCCTCCTGGACAAAGAAATAGAGAAGTCATATCCTGGGGAAGTGGGAGACAGAATTCACCGCGTATGGGCCAGCCTGGATCGGGCTCCATGCCATCAAGATCCACTTCTCACACTTCAGATTTCAACCCGAATTCTGGTTCAGACCAAAGAGTAGTTAATGGAGGTGTTCCCTGGCCATCGCCTTGCCCATCTCCTTCCTCTCGCCCACCTTCTCGCTACCAGTCAGGTCCCAACTCTCTTCCACCTCGGGCAGCCACCCCTACACGGCCGCCCTCCAGGCCCCCCTCGCGGCCATCCAGACCCCCGTCTCACCCCTCTGCTCATGGTTCTCCAGCTCCTGTCTCTACTATGCCTAAACGCATGTCTTCAGAAGGGCCTCCAAGGATGTCCCCAAAGGCCCAGCGACATCCTCGAAATCACAGAGTTTCTGCTGGGAGGGGTTCCATATCCAGTGGCCTAGAATTTGTATCCCACAACCCACCCAGTGAAGCAGCTACTCCTCCAGTAGCAAGGACCAGTCCCTCGGGGGGAACGTGGTCATCAGTGGTCAGTGGGGTTCCAAGATTATCCCCTAAAACTCATAGACCCAGGTCTCCCAGACAGAACAGTATTGGAAATACCCCCAGTGGGCCAGTTCTTGCTTCTCCCCAAGCTGGTATTATTCCAACTGAAGCTGTTGCCATGCCTATTCCAGCTGCATCTCCTACGCCTGCTAGTCCTGCATCGAACAGAGCTGTTACCCCTTCTAGTGAGGCTAAAGATTCCAGGCTTCAAGATCAGAGGCAGAACTCTCCTGCAGGGAATAAAGAAAATATTAAACCCAATGAAACATCACCTAGCTTCTCAAAAGCTGAAAACAAAGGTATATCACCAGTTGTTTCTGAACATAGAAAACAGATTGATGATTTAAAGAAATTTAAGAATGATTTTAGGTTACAGCCAAGTTCTACTTCTGAATCTATGGATCAACTACTAAACAAAAATAGAGAGGGAGAAAAATCAAGAGATTTGATCAAAGACAAAATTGAACCAAGTGCTAAGGATTCTTTCATTGAAAATAGCAGCAGCAACTGTACCAGTGGCAGCAGCAAGCCGAATAGCCCCAGCATTTCCCCTTCAATACTTAGTAACACGGAGCACAAGAGGGGACCTGAGGTCACTTCCCAAGGGGTTCAGACTTCCAGCCCAGCATGTAAACAAGAGAAAGACGATAAGGAAGAGAAGAAAGACGCAGCTGAGCAAGTTAGGAAATCAACATTGAATCCCAATGCAAAGGAGTTCAACCCACGTTCCTTCTCTCAGCCAAAGCCTTCTACTACCCCAACTTCACCTCGGCCTCAAGCACAACCTAGCCCATCTATGGTGGGTCATCAACAGCCAACTCCAGTTTATACTCAGCCTGTTTGTTTTGCACCAAATATGATGTATCCAGTCCCAGTGAGCCCAGGCGTGCAACCTTTATACCCAATACCTATGACGCCCATGCCAGTGAATCAAGCCAAGACATATAGAGCAGTACCAAATATGCCCCAACAGCGGCAAGACCAGCATCATCAGAGTGCCATGATGCACCCAGCGTCAGCAGCGGGCCCACCGATTGCAGCCACCCCACCAGCTTACTCCACGCAATATGTTGCCTACAGTCCTCAGCAGTTCCCAAATCAGCCCCTTGTTCAGCATGTGCCACATTATCAGTCTCAGCATCCTCATGTCTATAGTCCTGTAATACAGGGTAATGCTAGAATGATGGCACCACCAACACACGCCCAGCCTGGTTTAGTATCTTCTTCAGCAACTCAGTACGGGGCTCATGAGCAGACGCATGCGATGTATGCATGTCCCAAATTACCATACAACAAGGAGACAAGCCCTTCTTTCTACTTTGCCATTTCCACGGGCTCCCTTGCTCAGCAGTATGCGCACCCTAACGCTACCCTGCACCCACATACTCCACACCCTCAGCCTTCAGCTACCCCCACTGGACAGCAGCAAAGCCAACATGGTGGAAGTCATCCTGCACCCAGTCCTGTTCAGCACCATCAGCACCAGGCCGCCCAGGCTCTCCATCTGGCCAGTCCACAGCAGCAGTCAGCCATTTACCACGCGGGGCTTGCGCCAACTCCACCCTCCATGACACCTGCCTCCAACACGCAGTCGCCACAGAATAGTTTCCCAGCAGCACAACAGACTGTCTTTACGATCCATCCTTCTCACGTTCAGCCGGCGTATACCAACCCACCCCACATGGCCCACGTACCTCAGGCTCATGTACAGTCAGGAATGGTTCCTTCTCATCCAACTGCCCATGCGCCAATGATGCTAATGACGACACAGCCACCCGGCGGTCCCCAGGCCGCCCTCGCTCAAAGTGCACTACAGCCCATTCCAGTCTCGACAACAGCGCATTTCCCCTATATGACGCACCCTTCAGTACAAGCCCACCACCAACAGCAGTTGTAA

Back to List